Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collection of Whole Blood Specimens From Pregnant Women at Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma

NCT01429389 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.

NCT NCT01429389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01429389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collection of Whole Blood Specimens From Pregnant Women at Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma
Lead sponsor
Sequenom, Inc.
Phase
Observational
Overall status
Recruiting
Start date
May 31, 2011
Completion date
March 31, 2028
Enrollment
2,000 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome, fetal aneuploidy